Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Candel Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
Revenues0.10.16.6
            Revenue growth0.0%-98.1% 
Cost of goods sold0.00.09.2
Gross profit0.10.1-2.6
            Gross margin100.0%100.0%-38.7%
Selling, general and administrative25.913.9 
General and administrative  2.6
EBIT-34.0-16.3-9.0
            EBIT margin-27220.0%-13056.8%-136.8%
Pre-tax income-36.1-17.7-8.2
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-36.1-17.7-8.2
            Net margin-28899.2%-14144.0%-124.7%
 
Diluted EPS($1.91)($1.52) 
Shares outstanding (diluted)18.911.6 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy